RECTAL CANCER RECURRENT
Clinical trials for RECTAL CANCER RECURRENT explained in plain language.
Never miss a new study
Get alerted when new RECTAL CANCER RECURRENT trials appear
Sign up with your email to follow new studies for RECTAL CANCER RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Rectal cancer combo trial pulled before starting
Disease control TerminatedThis study was designed to test a combination of two drugs, regorafenib and lorigerlimab, in people with a certain type of rectal cancer that came back after initial treatment. The goal was to see if the combination was safe and effective. However, the study was withdrawn before …
Matched conditions: RECTAL CANCER RECURRENT
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New study aims to make complex cancer surgery safer and more effective
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at ways to improve the surgical process and recovery for people with advanced or recurrent rectal cancer that has spread to nearby organs. Researchers will standardize the steps the surgical team follows and track patient outcomes, including quality of life after…
Matched conditions: RECTAL CANCER RECURRENT
Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 06:51 UTC